Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis

We describe a case of prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in a patient receiving ocrelizumab for multiple sclerosis. Viral RNA shedding, signs, and symptoms persisted for 69 days with resolution after administration of convalescent plasma and antiviral th...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Open Forum Infect Dis
Glavni autori: Gibson, Elena G, Pender, Melissa, Angerbauer, Michael, Cook, Craig, Jones, Barbara, Spivak, Adam M, Spivak, Emily S, Swaminathan, Sankar
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2021
Teme:
Brief Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8083367/
https://ncbi.nlm.nih.gov/pubmed/34258310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofab176
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items